The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease
Saved in:
Main Authors: | Anna E. Płatek, Julia A. Szymańska |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2023-09-01
|
Series: | Gastroenterology Review |
Subjects: | |
Online Access: | https://www.termedia.pl/The-impact-of-fasting-on-cardiovascular-risk-control-in-patients-with-metabolic-dysfunction-associated-steatotic-liver-disease,41,51455,1,1.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Myrsini Orfanidou, et al.
Published: (2024-12-01) -
FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease
by: Mário Reis Álvares-da-Silva, et al.
Published: (2025-01-01) -
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
by: Gong Feng, et al.
Published: (2025-03-01) -
Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01) -
Metabolic dysfunction-associated steatotic liver disease
by: Chieh Chen, et al.
Published: (2024-12-01)